The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01087125
Recruitment Status : Unknown
Verified January 2019 by Bristol-Myers Squibb. Recruitment status was: Recruiting
First Posted : March 16, 2010
Last Update Posted : February 1, 2019
University of California, San Diego
The Organization of Teratology Information Specialists
The purpose of the abatacept pregnancy registry is to monitor planned and unplanned pregnancies exposed to abatacept, to evaluate the possible teratogenic effects (that is, any abnormal development) of this medication in the pregnancy outcome and to follow live born infants for one year after birth.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Currently pregnant women who agree to the conditions and requirements of the study including the interview schedule, release of medical records, and the physical examination of live born infants
Women who come in first contact with the project after prenatal diagnosis of a fetal abnormality